Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

Clinical trial NCT03751072 · COMPLETED

Trial details

NCT number: NCT03751072
Sponsor: Group for Research in Adult Acute Lymphoblastic Leukemia
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia With Failed Remission

Start date: 2018-07-16
Primary completion: 2018-11-30
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.